In this series, we measure how swiftly a company turns cash into goods or services and back into cash. We'll use a quick, relatively foolproof tool known as the cash conversion cycle, or CCC for short ...

There's no foolproof way to know the future for Syneron Medical (Nasdaq: ELOS) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your ...

For the quarter ended Sep. 30 (Q3), Syneron Medical missed estimates on revenues and missed estimates on earnings per share. Compared to the prior-year quarter, revenue increased and GAAP loss per ...

BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader ...

YOKNEAM, Israel, Oct. 3, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, honored Dr. Shimon Eckhouse, its founder and the inventor of IPL ...

YOKNEAM, Israel & WAYLAND, Mass.--(BUSINESS WIRE)--Syneron Medical Ltd. (NASDAQ:ELOS) and Candela Corporation (NASDAQ:CLZR) announced today that they have entered into a definitive agreement to ...

Whether you want to dismiss it as vanity or not, the fact remains that the non-surgical aesthetics market is worth over $2 billion a year. If Israel's SyneronMedical (NASDAQ:ELOS) has anything to say ...

BEIJING, Dec. 18, 2025 /PRNewswire/ -- Syneron Bio, an macrocyclic peptide drug discovery company driven by intelligent high-throughput platform, has successfully completed its Series A and A+ ...

IRVINE, Calif. and LONDON, April 3, 2017 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, and Apax Partners, a leading global private equity ...

BEIJING, April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th ...

YOKNEAM, ISRAEL -- (MARKET WIRE) -- 11/10/2008 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos TM combined-energy medical aesthetic devices, today ...

Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Syneron Candela's portfolio, further strengthening their position in multi-application, multi-technology devices ...